Innovative Surface Technologies, Inc. (ISurTec) was created to continue technology and product development activities conducted over 35 years at three other laboratories. Patrick Guire Ph.D. had previously co-founded BSI (now SurModics, Inc.) in 1979. ISurTec is expected to function largely as a business incubator, creating and licensing new inventions in the area of biotechnology and surface modification for medical device, biotechnology, and higher-value industrial applications.

 

ISurTec is expected to remain privately owned and grow from federal and private grants and contracts plus reinvestment of profits, to a size of up to 100, encompassing eight to ten technical teams in such specialties as cell biology, microbiology, biophysics/biomedical engineering, and chemical engineering. Commercial development of ISurTec’s intellectual property will be accomplished largely through the formation of new start-up joint-venture companies, which will be financed partially by ISurTec and may become candidates for public ownership.